ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 1155

$609K Total Retail Price of All Prescriptions

Rank: 16 out of 1155

627 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,440 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 452 412 1 2
LISINOPRIL 329 301 2 1
HYDROCODONE-ACETAMINOPHEN 303 242 S3 3 4
POTASSIUM CHLORIDE 268 228 4 16
SIMVASTATIN 259 233 5 3
METFORMIN HCL 256 231 6 7
OMEPRAZOLE 246 208 7 5
FUROSEMIDE 238 209 8 8
ZOLPIDEM TARTRATE 219 140 9 21
AMLODIPINE BESYLATE 216 201 10 6
LOVASTATIN 164 145 11 13
DICLOFENAC SODIUM 158 137 12 93
CITALOPRAM HBR 156 123 13 19
METOPROLOL TARTRATE 145 121 14 14
TRAZODONE HCL 138 128 15 22
ALENDRONATE SODIUM 136 124 16 25
TAMSULOSIN HCL 133 133 17 27
ALLOPURINOL 129 103 18 29
CRESTOR 129 93 18 34
ATENOLOL 129 118 18 10
PANTOPRAZOLE SODIUM 120 103 21 47
ATORVASTATIN CALCIUM 117 114 22 12
HYDROCHLOROTHIAZIDE 115 98 23 9
OXYCODONE-ACETAMINOPHEN 90 68 S2 24 45
TRAMADOL HCL 87 80 25 32
LOSARTAN POTASSIUM 85 80 26 18
AZITHROMYCIN 84 69 27 57
SERTRALINE HCL 84 64 27 24
PROAIR HFA 82 54 29 31
RISPERIDONE 79 67 30 73
GABAPENTIN 77 67 31 15
RANITIDINE HCL 73 48 32 33
DONEPEZIL HCL 73 62 32 41
WARFARIN SODIUM 73 47 32 11
TRIAMTERENE-HCTZ 71 71 35 51
FENTANYL 71 65 S2 35 64
DIVALPROEX SODIUM 70 47 37 106
NAMENDA 69 58 38 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 62 39 26
LANTUS 67 67 39 39
ADVAIR DISKUS 63 39 41 35
POLYETHYLENE GLYCOL 3350 62 53 42 59
METOPROLOL SUCCINATE 60 59 43 17
CARVEDILOL 57 47 44 28
ESCITALOPRAM OXALATE 57 34 44 95
OXYCODONE HCL 56 28 S2 46 23
JANTOVEN 55 55 47 136
FAMOTIDINE 55 55 47 76
DIGOXIN 54 43 49 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.